News for Kythera Biopharmaceuticals Inc - Google Finance

Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)

Fri, 14 Jun 2013 18:36:22 GMT

Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)
Insider Monkey (blog) - Jun 14, 2013

Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds' portfolio at the end of March. KYTH investors should be aware of an increase in support from the world's most elite money managers lately.

KYTHERA BIOPHARMACEUTICALS INC. : KYTHERA Biopharmaceuticals to ...

Thu, 06 Jun 2013 20:30:40 GMT

KYTHERA BIOPHARMACEUTICALS INC. : KYTHERA Biopharmaceuticals to ...
4-traders (press release) - Jun 6, 2013

LOS ANGELES, June 6, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman Sachs 34th Annual Global Healthcare ...

Kythera Biopharmaceuticals Now Covered by Thomson Reuters/Verus (KYTH)

Mon, 20 May 2013 20:17:11 GMT

Kythera Biopharmaceuticals Now Covered by Thomson Reuters/Verus (KYTH)
Daily Political - May 20, 2013

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.

Hedge Funds Are Buying Endocyte, Inc. (ECYT)

Mon, 17 Jun 2013 12:50:30 GMT

Hedge Funds Are Buying Endocyte, Inc. (ECYT)
Insider Monkey (blog) - Jun 17, 2013

These stocks are Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Keryx Biopharmaceuticals (NASDAQ:KERX), Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), and Kythera Biopharmaceuticals Inc (NASDAQ:KYTH).

Kythera, MannKind Among Week's Biggest Gainers

Fri, 07 Jun 2013 22:02:48 GMT

Kythera, MannKind Among Week's Biggest Gainers
Los Angeles Business Journal - Jun 7, 2013

Among the biggest gainers was Kythera Biopharmaceuticals Inc., rising 14 percent to $25.39. The gain came after the Calabasas developer of injectable fat dissolver for the aesthetic market made a presentation at an investor meeting.

Is Astex Pharmaceuticals, Inc. (ASTX) Going to Burn These Hedge Funds?

Wed, 12 Jun 2013 20:57:00 GMT

Is Astex Pharmaceuticals, Inc. (ASTX) Going to Burn These Hedge Funds?
Insider Monkey (blog) - Jun 12, 2013

These stocks are Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Keryx Biopharmaceuticals (NASDAQ:KERX), Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Endocyte, Inc. (NASDAQ:ECYT), and Kythera Biopharmaceuticals Inc (NASDAQ:KYTH). This group ...

KYTHERA Biopharma To Present At Goldman Sachs Conference ; Webcast At ...

Thu, 13 Jun 2013 14:03:31 GMT

KYTHERA Biopharma To Present At Goldman Sachs Conference ; Webcast At ...
NASDAQ - Jun 13, 2013

(RTTNews.com) - KYTHERA Biopharmaceuticals, Inc. ( KYTH ) will present at the Goldman Sachs 34th Annual Global Healthcare Conference in Palos Verdes, CA.

Hedge Funds Are Buying Keryx Biopharmaceuticals (KERX)

Mon, 03 Jun 2013 14:01:00 GMT

Hedge Funds Are Buying Keryx Biopharmaceuticals (KERX)
Insider Monkey (blog) - Jun 3, 2013

These stocks are Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), Endocyte, Inc. (NASDAQ:ECYT), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL).

Drug Delivery Partnering Terms and Agreements

Thu, 13 Jun 2013 17:11:58 GMT

Drug Delivery Partnering Terms and Agreements
Sacramento Bee - Jun 13, 2013

Big pharma drug delivery partnering company profiles Abbott Actavis Inc (formerly Watson Pharmaceuticals) Actavis (merged with Watson Pharmaceuticals Oct 2012) Actelion Allergan Amgen Astellas AstraZeneca Baxter International Bayer Biogen Idec ...

Kythera Biopharmaceuticals Inc Announces Positive Magnetic Resonance Imaging (MRI) Results from Phase IIb Study of ATX-101 in Reduction of Submental Fat or 'Double Chin'

Sat, 13 Apr 2013 20:45:00 GMT

Kythera Biopharmaceuticals Inc Announces Positive Magnetic Resonance Imaging (MRI) Results from Phase IIb Study of ATX-101 in Reduction of Submental Fat or 'Double Chin'
Reuters Key Development - Apr 13, 2013